Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120
The HIV-1 envelope protein (Env) of early-replicating viruses encodes several distinct transmission signatures. One such signature involves a reduced number of potential N-linked glycosylation sites (PNGs). This transmission signature underscores the importance of posttranslational modifications in...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 115; no. 10; pp. 2443 - 2448 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
06.03.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The HIV-1 envelope protein (Env) of early-replicating viruses encodes several distinct transmission signatures. One such signature involves a reduced number of potential N-linked glycosylation sites (PNGs). This transmission signature underscores the importance of posttranslational modifications in the fitness of early-replicating isolates. An additional signature in Env involves the overrepresentation of basic amino acid residues at a specific position in the Env signal peptide (SP). In this report, we investigated the potential impact of this SP signature on gp120 glycosylation and antigenicity. Two recombinant gp120s were constructed, one derived from an isolate that lacks this signature and a second from an early-replicating isolate that includes this signature. Chimeric gp120s were also constructed in which the two SPs were swapped between the isolates. All four gp120s were probed with glycan-, structure- and receptor- specific probes in a surface plasmon resonance binding assay. We found that the SP of Env influences qualitative aspects of Env glycosylation that in turn affect the antigenicity of Env in a major way. The SP impacts the affinity of Env for DC-SIGN, a lectin receptor expressed on dendritic cells that is believed to play a role in mucosal transmission. Additionally, affinity for the monoclonal antibodies 17b and A32, which recognize a CD4-induced, open conformation of Env is also altered. These results demonstrate that natural variation in the SP of HIV Env can significantly impact the antigenicity of mature gp120. Thus, the SP is likely subject to antibody-mediated immune pressure. |
---|---|
AbstractList | The HIV-1 envelope protein (Env) of early-replicating viruses encodes several distinct transmission signatures. One such signature involves a reduced number of potential N-linked glycosylation sites (PNGs). This transmission signature underscores the importance of posttranslational modifications in the fitness of early-replicating isolates. An additional signature in Env involves the overrepresentation of basic amino acid residues at a specific position in the Env signal peptide (SP). In this report, we investigated the potential impact of this SP signature on gp120 glycosylation and antigenicity. Two recombinant gp120s were constructed, one derived from an isolate that lacks this signature and a second from an early-replicating isolate that includes this signature. Chimeric gp120s were also constructed in which the two SPs were swapped between the isolates. All four gp120s were probed with glycan-, structure- and receptor- specific probes in a surface plasmon resonance binding assay. We found that the SP of Env influences qualitative aspects of Env glycosylation that in turn affect the antigenicity of Env in a major way. The SP impacts the affinity of Env for DC-SIGN, a lectin receptor expressed on dendritic cells that is believed to play a role in mucosal transmission. Additionally, affinity for the monoclonal antibodies 17b and A32, which recognize a CD4-induced, open conformation of Env is also altered. These results demonstrate that natural variation in the SP of HIV Env can significantly impact the antigenicity of mature gp120. Thus, the SP is likely subject to antibody-mediated immune pressure.The HIV-1 envelope protein (Env) of early-replicating viruses encodes several distinct transmission signatures. One such signature involves a reduced number of potential N-linked glycosylation sites (PNGs). This transmission signature underscores the importance of posttranslational modifications in the fitness of early-replicating isolates. An additional signature in Env involves the overrepresentation of basic amino acid residues at a specific position in the Env signal peptide (SP). In this report, we investigated the potential impact of this SP signature on gp120 glycosylation and antigenicity. Two recombinant gp120s were constructed, one derived from an isolate that lacks this signature and a second from an early-replicating isolate that includes this signature. Chimeric gp120s were also constructed in which the two SPs were swapped between the isolates. All four gp120s were probed with glycan-, structure- and receptor- specific probes in a surface plasmon resonance binding assay. We found that the SP of Env influences qualitative aspects of Env glycosylation that in turn affect the antigenicity of Env in a major way. The SP impacts the affinity of Env for DC-SIGN, a lectin receptor expressed on dendritic cells that is believed to play a role in mucosal transmission. Additionally, affinity for the monoclonal antibodies 17b and A32, which recognize a CD4-induced, open conformation of Env is also altered. These results demonstrate that natural variation in the SP of HIV Env can significantly impact the antigenicity of mature gp120. Thus, the SP is likely subject to antibody-mediated immune pressure. The HIV-1 envelope protein (Env) of early-replicating viruses encodes several distinct transmission signatures. One such signature involves a reduced number of potential N-linked glycosylation sites (PNGs). This transmission signature underscores the importance of posttranslational modifications in the fitness of early-replicating isolates. An additional signature in Env involves the overrepresentation of basic amino acid residues at a specific position in the Env signal peptide (SP). In this report, we investigated the potential impact of this SP signature on gp120 glycosylation and antigenicity. Two recombinant gp120s were constructed, one derived from an isolate that lacks this signature and a second from an early-replicating isolate that includes this signature. Chimeric gp120s were also constructed in which the two SPs were swapped between the isolates. All four gp120s were probed with glycan-, structure- and receptor- specific probes in a surface plasmon resonance binding assay. We found that the SP of Env influences qualitative aspects of Env glycosylation that in turn affect the antigenicity of Env in a major way. The SP impacts the affinity of Env for DC-SIGN, a lectin receptor expressed on dendritic cells that is believed to play a role in mucosal transmission. Additionally, affinity for the monoclonal antibodies 17b and A32, which recognize a CD4-induced, open conformation of Env is also altered. These results demonstrate that natural variation in the SP of HIV Env can significantly impact the antigenicity of mature gp120. Thus, the SP is likely subject to antibody-mediated immune pressure. Significant heterogeneity exists in the structure and antigenicity of HIV-1 envelope protein (Env) gp120 due, in part, to various posttranslational modifications. Using glycan and antigenic analysis, we show that the signal peptide (SP) of HIV Env can impact the glycan profile of gp120, which in turn impacts antigenicity of the mature protein. Thus, although the SP is not present in the mature gp120 protein, it is likely subject to immune pressure. Moreover, to the extent that glycan content impacts transmission fitness, variation in the SP may influence transmission. These observations potentially help us better understand both the early events in HIV transmission as well as the mechanisms whereby HIV evades humoral immune responses, providing additional information for HIV vaccine design. The HIV-1 envelope protein (Env) of early-replicating viruses encodes several distinct transmission signatures. One such signature involves a reduced number of potential N-linked glycosylation sites (PNGs). This transmission signature underscores the importance of posttranslational modifications in the fitness of early-replicating isolates. An additional signature in Env involves the overrepresentation of basic amino acid residues at a specific position in the Env signal peptide (SP). In this report, we investigated the potential impact of this SP signature on gp120 glycosylation and antigenicity. Two recombinant gp120s were constructed, one derived from an isolate that lacks this signature and a second from an early-replicating isolate that includes this signature. Chimeric gp120s were also constructed in which the two SPs were swapped between the isolates. All four gp120s were probed with glycan-, structure- and receptor- specific probes in a surface plasmon resonance binding assay. We found that the SP of Env influences qualitative aspects of Env glycosylation that in turn affect the antigenicity of Env in a major way. The SP impacts the affinity of Env for DC-SIGN, a lectin receptor expressed on dendritic cells that is believed to play a role in mucosal transmission. Additionally, affinity for the monoclonal antibodies 17b and A32, which recognize a CD4-induced, open conformation of Env is also altered. These results demonstrate that natural variation in the SP of HIV Env can significantly impact the antigenicity of mature gp120. Thus, the SP is likely subject to antibody-mediated immune pressure. |
Author | Yolitz, Jason Cicala, Claudia Chang, Julia Nawaz, Fatima Wei, Danlan Van Ryk, Donald Fauci, Anthony S. Schwing, Catherine Arthos, James |
Author_xml | – sequence: 1 givenname: Jason surname: Yolitz fullname: Yolitz, Jason organization: National Institutes of Health–Johns Hopkins University Graduate Partnership Program, National Institutes of Health, Bethesda, MD 20892 – sequence: 2 givenname: Catherine surname: Schwing fullname: Schwing, Catherine organization: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 – sequence: 3 givenname: Julia surname: Chang fullname: Chang, Julia organization: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 – sequence: 4 givenname: Donald surname: Van Ryk fullname: Van Ryk, Donald organization: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 – sequence: 5 givenname: Fatima surname: Nawaz fullname: Nawaz, Fatima organization: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 – sequence: 6 givenname: Danlan surname: Wei fullname: Wei, Danlan organization: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 – sequence: 7 givenname: Claudia surname: Cicala fullname: Cicala, Claudia organization: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 – sequence: 8 givenname: James surname: Arthos fullname: Arthos, James organization: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 – sequence: 9 givenname: Anthony S. surname: Fauci fullname: Fauci, Anthony S. organization: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29463753$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kbFv1DAYxS1URK8HMxMoEkuXtJ8dO7YXpKqitFIlBqCr5Thfgk85O8S-Svffk3ClhQ4Mlge_9_T8eyfkKMSAhLylcEZBVudjsOmMSsZqJikVL8iKgqZlzTUckRUAk6XijB-Tk5Q2AKCFglfkmGleV1JUK3L31ffBDsWIY_YtFrErrm_uCgz3OMQRi3GKGX0o_Ha0LqeiH_Yupv1gs4-hsKGdT_Y9Bu983i_2fqQMXpOXnR0Svnm41-T71advl9fl7ZfPN5cXt6UToHPpwLa11AANl3XNWym0oqKpLe2YQskcdw1tra46zrGBrlOq6VAzxK6iDlm1Jh8PueOu2WLrMOTJDmac_NZOexOtN_--BP_D9PHeCCWllvUccPoQMMWfO0zZbH1yOAw2YNwlwwBmsJWcYa_Jh2fSTdxNM7xFxRgFxfUS-P7vRo9V_iCfBecHgZtiShN2jxIKZhnVLKOap1Fnh3jmmFn_HmD-kh_-43t38G1SjtNTk1qAVEJVvwDpFrDD |
CitedBy_id | crossref_primary_10_1002_mco2_261 crossref_primary_10_3389_fimmu_2024_1476924 crossref_primary_10_3390_cells9071584 crossref_primary_10_3390_v14081729 crossref_primary_10_1038_s41467_021_21402_1 crossref_primary_10_1128_JVI_02221_20 crossref_primary_10_3390_v14081746 crossref_primary_10_1002_JLB_4MR0120_208R crossref_primary_10_1016_j_jmb_2019_04_016 crossref_primary_10_1186_s13578_022_00809_3 crossref_primary_10_3390_vaccines9020176 crossref_primary_10_1016_j_talanta_2019_120551 crossref_primary_10_1016_j_biotechadv_2023_108283 crossref_primary_10_3390_v14030478 crossref_primary_10_1371_journal_ppat_1008476 crossref_primary_10_1016_j_isci_2019_10_030 crossref_primary_10_1016_j_vaccine_2018_03_091 crossref_primary_10_3389_fimmu_2023_1143034 crossref_primary_10_1016_j_vaccine_2018_09_056 crossref_primary_10_1016_j_jmb_2021_167332 crossref_primary_10_1016_j_vaccine_2023_09_059 crossref_primary_10_3390_v15020274 crossref_primary_10_1016_j_pep_2021_106013 crossref_primary_10_1089_aid_2018_0102 crossref_primary_10_3390_v11111012 crossref_primary_10_3390_cancers12113101 crossref_primary_10_1016_j_alcohol_2021_04_003 crossref_primary_10_3390_microorganisms8050624 crossref_primary_10_3390_v14050853 crossref_primary_10_1042_BSR20211930 crossref_primary_10_3390_vaccines13020148 crossref_primary_10_1097_QAD_0000000000002690 crossref_primary_10_1016_j_virol_2024_110147 crossref_primary_10_1371_journal_ppat_1009185 |
Cites_doi | 10.1128/JVI.79.10.6528-6531.2005 10.1016/S0140-6736(00)04331-2 10.1189/jlb.0503208 10.1126/science.1066371 10.1073/pnas.89.21.10247 10.1006/viro.1994.1531 10.1038/nature10373 10.1128/JVI.00171-11 10.1128/JVI.05053-11 10.1097/COH.0b013e32832d9fef 10.1128/jvi.67.1.584-588.1993 10.1111/j.1432-1033.1981.tb06300.x 10.1016/S0092-8674(00)80694-7 10.1128/JVI.02108-09 10.1126/science.1093137 10.1093/bmb/58.1.19 10.1084/jem.20042510 10.1101/cshperspect.a006866 10.1016/S1074-7613(02)00259-5 10.1073/pnas.1304288110 10.1016/S0021-9258(18)86956-3 10.1016/j.febslet.2006.05.070 10.1096/fj.02-0811com 10.1038/nri3516 10.1006/viro.2000.0357 10.1093/glycob/cwh106 10.1128/jvi.67.12.7383-7393.1993 10.1126/science.1178746 10.1016/S0021-9258(18)37849-9 10.1126/science.1084238 10.1128/jvi.70.2.1100-1108.1996 10.1128/JVI.00105-10 10.1074/jbc.M104565200 10.1128/JVI.76.14.7306-7321.2002 10.2174/157016207782418560 10.1128/JVI.77.2.1337-1346.2003 10.1073/pnas.0911796106 10.1128/JVI.02132-08 10.1371/journal.ppat.1002209 10.1128/JVI.72.6.4694-4703.1998 10.1111/febs.13530 10.1128/jvi.67.7.3978-3988.1993 10.1111/j.1399-3054.1988.tb09192.x 10.1371/journal.pone.0023673 10.1086/429411 10.1016/S0962-8924(98)01360-9 10.1073/pnas.93.18.9606 10.1128/JVI.02164-14 10.1073/pnas.0802203105 10.1128/JVI.03235-14 10.7554/eLife.26067 10.1128/JVI.79.9.5762-5773.2005 10.1038/nri1960 10.1038/nature01470 10.1097/COH.0b013e3282f2982c |
ContentType | Journal Article |
Copyright | Volumes 1–89 and 106–114, copyright as a collective work only; author(s) retains copyright to individual articles Copyright © 2018 the Author(s). Published by PNAS. Copyright National Academy of Sciences Mar 6, 2018 Copyright © 2018 the Author(s). Published by PNAS. 2018 |
Copyright_xml | – notice: Volumes 1–89 and 106–114, copyright as a collective work only; author(s) retains copyright to individual articles – notice: Copyright © 2018 the Author(s). Published by PNAS. – notice: Copyright National Academy of Sciences Mar 6, 2018 – notice: Copyright © 2018 the Author(s). Published by PNAS. 2018 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QG 7QL 7QP 7QR 7SN 7SS 7T5 7TK 7TM 7TO 7U9 8FD C1K FR3 H94 M7N P64 RC3 7X8 5PM |
DOI | 10.1073/pnas.1722627115 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Nucleic Acids Abstracts Ecology Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Entomology Abstracts Genetics Abstracts Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Chemoreception Abstracts Immunology Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Virology and AIDS Abstracts MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
EISSN | 1091-6490 |
EndPage | 2448 |
ExternalDocumentID | PMC5877976 29463753 10_1073_pnas_1722627115 26507858 |
Genre | Journal Article Research Support, N.I.H., Intramural |
GrantInformation_xml | – fundername: Intramural NIH HHS grantid: Z01 AI000883 – fundername: Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID) grantid: AI000883-11 |
GroupedDBID | --- -DZ -~X .55 0R~ 123 29P 2AX 2FS 2WC 4.4 53G 5RE 5VS 85S AACGO AAFWJ AANCE ABBHK ABOCM ABPLY ABPPZ ABTLG ABXSQ ABZEH ACGOD ACHIC ACIWK ACNCT ACPRK ADQXQ ADULT AENEX AEUPB AEXZC AFFNX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS AQVQM BKOMP CS3 D0L DCCCD DIK DU5 E3Z EBS EJD F5P FRP GX1 H13 HH5 HYE IPSME JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST KQ8 L7B LU7 N9A N~3 O9- OK1 PNE PQQKQ R.V RHI RNA RNS RPM RXW SA0 SJN TAE TN5 UKR W8F WH7 WOQ WOW X7M XSW Y6R YBH YKV YSK ZCA ~02 ~KM AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QG 7QL 7QP 7QR 7SN 7SS 7T5 7TK 7TM 7TO 7U9 8FD C1K FR3 H94 M7N P64 RC3 7X8 5PM |
ID | FETCH-LOGICAL-c509t-c0ad67900b47664d759815b6a1f28e72c4cb1da93f44eb0ff88bfe92eef31ce23 |
ISSN | 0027-8424 1091-6490 |
IngestDate | Thu Aug 21 18:08:30 EDT 2025 Fri Jul 11 05:07:51 EDT 2025 Mon Jun 30 08:35:47 EDT 2025 Sat May 31 02:08:42 EDT 2025 Tue Jul 01 03:19:46 EDT 2025 Thu Apr 24 23:01:12 EDT 2025 Fri May 30 11:17:21 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | signal peptide antigenicity gp120 vaccine HIV |
Language | English |
License | Copyright © 2018 the Author(s). Published by PNAS. This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND). |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c509t-c0ad67900b47664d759815b6a1f28e72c4cb1da93f44eb0ff88bfe92eef31ce23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Contributed by Anthony S. Fauci, January 29, 2018 (sent for review January 2, 2018; reviewed by Mirko Paiardini and Guido Poli) Reviewers: M.P., Emory Vaccine Center, Yerkes National Primate Research Center; and G.P., San Raffaele Scientific Institute. Author contributions: J.Y., C.C., J.A., and A.S.F. designed research; J.Y., C.S., J.C., D.V.R., F.N., and D.W. performed research; D.V.R. contributed new reagents/analytic tools; J.Y., D.V.R., F.N., C.C., J.A., and A.S.F. analyzed data; and J.Y., C.C., J.A., and A.S.F. wrote the paper. |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC5877976 |
PMID | 29463753 |
PQID | 2022108496 |
PQPubID | 42026 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5877976 proquest_miscellaneous_2007113707 proquest_journals_2022108496 pubmed_primary_29463753 crossref_primary_10_1073_pnas_1722627115 crossref_citationtrail_10_1073_pnas_1722627115 jstor_primary_26507858 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-03-06 |
PublicationDateYYYYMMDD | 2018-03-06 |
PublicationDate_xml | – month: 03 year: 2018 text: 2018-03-06 day: 06 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Washington |
PublicationTitle | Proceedings of the National Academy of Sciences - PNAS |
PublicationTitleAlternate | Proc Natl Acad Sci U S A |
PublicationYear | 2018 |
Publisher | National Academy of Sciences |
Publisher_xml | – name: National Academy of Sciences |
References | e_1_3_3_50_2 e_1_3_3_16_2 e_1_3_3_18_2 e_1_3_3_39_2 e_1_3_3_12_2 e_1_3_3_37_2 e_1_3_3_14_2 e_1_3_3_35_2 e_1_3_3_56_2 e_1_3_3_33_2 e_1_3_3_54_2 e_1_3_3_10_2 e_1_3_3_31_2 e_1_3_3_52_2 e_1_3_3_40_2 e_1_3_3_5_2 e_1_3_3_7_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_23_2 e_1_3_3_48_2 e_1_3_3_25_2 e_1_3_3_46_2 e_1_3_3_1_2 e_1_3_3_44_2 e_1_3_3_3_2 e_1_3_3_21_2 e_1_3_3_42_2 e_1_3_3_51_2 e_1_3_3_17_2 e_1_3_3_19_2 e_1_3_3_38_2 e_1_3_3_13_2 e_1_3_3_36_2 e_1_3_3_15_2 e_1_3_3_34_2 e_1_3_3_32_2 e_1_3_3_55_2 e_1_3_3_11_2 e_1_3_3_30_2 e_1_3_3_53_2 e_1_3_3_6_2 e_1_3_3_8_2 e_1_3_3_28_2 e_1_3_3_49_2 Kapp K (e_1_3_3_20_2) 2009 e_1_3_3_24_2 e_1_3_3_47_2 e_1_3_3_26_2 e_1_3_3_45_2 e_1_3_3_2_2 e_1_3_3_43_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_41_2 |
References_xml | – ident: e_1_3_3_13_2 doi: 10.1128/JVI.79.10.6528-6531.2005 – ident: e_1_3_3_1_2 doi: 10.1016/S0140-6736(00)04331-2 – ident: e_1_3_3_35_2 doi: 10.1189/jlb.0503208 – ident: e_1_3_3_41_2 doi: 10.1126/science.1066371 – ident: e_1_3_3_7_2 doi: 10.1073/pnas.89.21.10247 – ident: e_1_3_3_23_2 doi: 10.1006/viro.1994.1531 – ident: e_1_3_3_29_2 doi: 10.1038/nature10373 – ident: e_1_3_3_48_2 doi: 10.1128/JVI.00171-11 – ident: e_1_3_3_14_2 doi: 10.1128/JVI.05053-11 – ident: e_1_3_3_6_2 doi: 10.1097/COH.0b013e32832d9fef – ident: e_1_3_3_21_2 doi: 10.1128/jvi.67.1.584-588.1993 – ident: e_1_3_3_28_2 doi: 10.1111/j.1432-1033.1981.tb06300.x – ident: e_1_3_3_36_2 doi: 10.1016/S0092-8674(00)80694-7 – ident: e_1_3_3_54_2 doi: 10.1128/JVI.02108-09 – ident: e_1_3_3_12_2 doi: 10.1126/science.1093137 – ident: e_1_3_3_10_2 doi: 10.1093/bmb/58.1.19 – ident: e_1_3_3_43_2 doi: 10.1084/jem.20042510 – ident: e_1_3_3_52_2 doi: 10.1101/cshperspect.a006866 – ident: e_1_3_3_38_2 doi: 10.1016/S1074-7613(02)00259-5 – ident: e_1_3_3_15_2 doi: 10.1073/pnas.1304288110 – ident: e_1_3_3_8_2 doi: 10.1016/S0021-9258(18)86956-3 – ident: e_1_3_3_51_2 doi: 10.1016/j.febslet.2006.05.070 – ident: e_1_3_3_18_2 doi: 10.1096/fj.02-0811com – ident: e_1_3_3_55_2 doi: 10.1038/nri3516 – ident: e_1_3_3_25_2 doi: 10.1006/viro.2000.0357 – ident: e_1_3_3_9_2 doi: 10.1093/glycob/cwh106 – ident: e_1_3_3_46_2 doi: 10.1128/jvi.67.12.7383-7393.1993 – ident: e_1_3_3_31_2 doi: 10.1126/science.1178746 – ident: e_1_3_3_49_2 doi: 10.1016/S0021-9258(18)37849-9 – ident: e_1_3_3_53_2 doi: 10.1126/science.1084238 – ident: e_1_3_3_30_2 doi: 10.1128/jvi.70.2.1100-1108.1996 – ident: e_1_3_3_22_2 doi: 10.1128/JVI.00105-10 – ident: e_1_3_3_40_2 doi: 10.1074/jbc.M104565200 – ident: e_1_3_3_33_2 doi: 10.1128/JVI.76.14.7306-7321.2002 – ident: e_1_3_3_45_2 doi: 10.2174/157016207782418560 – ident: e_1_3_3_39_2 doi: 10.1128/JVI.77.2.1337-1346.2003 – ident: e_1_3_3_56_2 doi: 10.1073/pnas.0911796106 – ident: e_1_3_3_4_2 doi: 10.1128/JVI.02132-08 – ident: e_1_3_3_16_2 doi: 10.1371/journal.ppat.1002209 – ident: e_1_3_3_47_2 doi: 10.1128/JVI.72.6.4694-4703.1998 – ident: e_1_3_3_32_2 doi: 10.1111/febs.13530 – ident: e_1_3_3_44_2 doi: 10.1128/jvi.67.7.3978-3988.1993 – ident: e_1_3_3_27_2 doi: 10.1111/j.1399-3054.1988.tb09192.x – ident: e_1_3_3_11_2 doi: 10.1371/journal.pone.0023673 – ident: e_1_3_3_2_2 doi: 10.1086/429411 – ident: e_1_3_3_19_2 doi: 10.1016/S0962-8924(98)01360-9 – start-page: 1 volume-title: Protein Transport into the Endoplasmic Reticulum year: 2009 ident: e_1_3_3_20_2 – ident: e_1_3_3_24_2 doi: 10.1073/pnas.93.18.9606 – ident: e_1_3_3_42_2 doi: 10.1128/JVI.02164-14 – ident: e_1_3_3_3_2 doi: 10.1073/pnas.0802203105 – ident: e_1_3_3_17_2 doi: 10.1128/JVI.03235-14 – ident: e_1_3_3_26_2 doi: 10.7554/eLife.26067 – ident: e_1_3_3_37_2 doi: 10.1128/JVI.79.9.5762-5773.2005 – ident: e_1_3_3_34_2 doi: 10.1038/nri1960 – ident: e_1_3_3_50_2 doi: 10.1038/nature01470 – ident: e_1_3_3_5_2 doi: 10.1097/COH.0b013e3282f2982c |
SSID | ssj0009580 |
Score | 2.430518 |
Snippet | The HIV-1 envelope protein (Env) of early-replicating viruses encodes several distinct transmission signatures. One such signature involves a reduced number of... Significant heterogeneity exists in the structure and antigenicity of HIV-1 envelope protein (Env) gp120 due, in part, to various posttranslational... |
SourceID | pubmedcentral proquest pubmed crossref jstor |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2443 |
SubjectTerms | Affinity Amino acids Antibodies, Monoclonal - metabolism Antigenicity Biological Sciences CD4 antigen DC-SIGN protein Dendritic Cells Disease transmission Fitness Glycan Glycoprotein gp120 Glycosylation HIV HIV Envelope Protein gp120 - chemistry HIV Envelope Protein gp120 - genetics HIV Envelope Protein gp120 - immunology HIV Envelope Protein gp120 - metabolism HIV-1 - immunology Human immunodeficiency virus Monoclonal antibodies Mucosa Peptides Protein Sorting Signals - genetics Recombinant Fusion Proteins - chemistry Recombinant Fusion Proteins - genetics Recombinant Fusion Proteins - immunology Recombinant Fusion Proteins - metabolism Replication Surface plasmon resonance Viral envelope proteins |
Title | Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120 |
URI | https://www.jstor.org/stable/26507858 https://www.ncbi.nlm.nih.gov/pubmed/29463753 https://www.proquest.com/docview/2022108496 https://www.proquest.com/docview/2007113707 https://pubmed.ncbi.nlm.nih.gov/PMC5877976 |
Volume | 115 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKeOEFMWAQNpCReBiqUvLh2MnjhDZNaJRJa6fyFMWO3VVUaUVaTd1fv3PsfHQUafASVY7jVL6fL3f27-4Q-qQozbmnAtfjLHOJiDK9pKSbhHksWKSUkjrA-fuQno_Jt0k06fVuu9ElKz4QdzvjSv5HqtAGctVRsv8g2WZQaIDfIF-4goTh-igZX82m2phcamZKbvbkwZuTRcUD0hFQC13L0kZClv3pfCMW5caw32yW1pXOxjkTlpgxXfqB17VXL5vvW1mzCYb19uFJG4xiNUTZd_uXw7a08U9NrrszZNyyPe-_Eje3tpRKE4DYoRlYjvB6Pms-Gdf6oGHzy1j8ejO7u1nhV9F7Hu3oVzBPXEpMhdCB3NFWK2UT5Fmjz-vqWGISO_2h_EFb6YrFRVYOwCwLaMDqUbbSbA9_pGfji4t0dDoZPUFPA_Avwnqbp8nWHJs0Fvaf1TmhWPjlwfBb5oxhtO7yVR5Sbjs2zOgFem6dD3xikLSPerJ4ifZr4eFjm4P88yt0baCFLbTwQmGAFq6hhS20sIUW3oIWBmjhLrT04xW0XqPx2eno67lrS3C4AizJlSu8LKcs8TxOGKUkZ1ES-xGnma-CWLJAEMH9PEtCRYiENa_imCuZBFKq0BcyCA_QXrEo5FuEc6J0ERLOlJ-RmEdZBGMzJTwVMi4Jd9CgnslU2Pz0ukzKPK14EixM9dSn7dQ76Lh5YGlSs_y960ElmqZfAI4Ji6PYQUe1rFK7sMs0ALvW92KSUAd9bG6D2tVnaVkhF2vdB2xzP2Qec9AbI9p28ITQkEWhg9iW0JsOOqX79p1idlOldo9ixsBBePeI9x6iZ-0KO0J7q99r-R4M5BX_UIH5Hvk3vrQ |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Signal+peptide+of+HIV+envelope+protein+impacts+glycosylation+and+antigenicity+of+gp120&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Yolitz%2C+Jason&rft.au=Schwing%2C+Catherine&rft.au=Chang%2C+Julia&rft.au=Van+Ryk%2C+Donald&rft.date=2018-03-06&rft.issn=1091-6490&rft.eissn=1091-6490&rft.volume=115&rft.issue=10&rft.spage=2443&rft_id=info:doi/10.1073%2Fpnas.1722627115&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0027-8424&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0027-8424&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0027-8424&client=summon |